Vericel (VCEL) EBIT Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,386.07% |
| 10 | Vericel | 1.69 Bn | 1.55 Bn | 49.27 Mn | 36.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.96% |
| Dec 31, 2025 | 21.30% |
| Sep 30, 2025 | 239.96% |
| Jun 30, 2025 | 66.36% |
| Mar 31, 2025 | -134.11% |
| Dec 31, 2024 | 45.15% |
| Sep 30, 2024 | 51.26% |
| Jun 30, 2024 | -1.17% |
| Mar 31, 2024 | 33.18% |
| Dec 31, 2023 | 109.22% |
| Sep 30, 2023 | 25.50% |
| Jun 30, 2023 | 34.36% |
| Mar 31, 2023 | -12.43% |
| Dec 31, 2022 | 46.95% |
| Sep 30, 2022 | -36.83% |
| Jun 30, 2022 | -143.55% |
| Mar 31, 2022 | -120.06% |
| Dec 31, 2021 | -66.30% |
| Sep 30, 2021 | -241.06% |
| Jun 30, 2021 | 55.38% |
| Mar 31, 2021 | 34.89% |
| Dec 31, 2020 | 33.43% |
| Sep 30, 2020 | 13.56% |
| Jun 30, 2020 | 58.62% |
| Mar 31, 2020 | -51.16% |
| Dec 31, 2019 | 53.63% |
| Sep 30, 2019 | 331.81% |
| Jun 30, 2019 | -375.74% |
| Mar 31, 2019 | 22.30% |
| Dec 31, 2018 | 403.36% |
| Sep 30, 2018 | 66.86% |
| Jun 30, 2018 | -68.43% |
| Mar 31, 2018 | 55.09% |
| Dec 31, 2017 | 0.00% |
| Sep 30, 2017 | 36.82% |
| Jun 30, 2017 | 49.42% |
| Mar 31, 2017 | -383.08% |
| Dec 31, 2016 | 124.03% |
| Sep 30, 2016 | -30.82% |
| Jun 30, 2016 | -120.04% |
| Mar 31, 2016 | 56.43% |
| Dec 31, 2015 | -111.39% |
| Sep 30, 2015 | 39.20% |
| Jun 30, 2015 | 73.42% |
| Mar 31, 2015 | 1.57% |
| Dec 31, 2014 | 52.38% |
| Sep 30, 2014 | -120.32% |
| Jun 30, 2014 | -62.82% |
| Mar 31, 2014 | 35.17% |
| Dec 31, 2013 | 35.36% |
| Sep 30, 2013 | 56.05% |
| Jun 30, 2013 | 43.72% |
| Mar 31, 2013 | 16.28% |
| Dec 31, 2012 | 2.77% |
| Sep 30, 2012 | -11.37% |
| Mar 31, 2012 | -36.71% |
| Sep 30, 2011 | -27.10% |